Figure 4
From: Prognostic values of novel biomarkers in patients with AL amyloidosis
Kaplan-Meier survival curve for overall survival according to scores given by levels of sST2 and GDF-15 in all patients of AL amyloidosis cohorts (A) and in subgroups of patients with advanced revised Mayo stages (stage III and IV).
